Short-and long-term outcomes of one-stage versus two-stage gastrectomy for perforated gastric cancer: a multicenter retrospective propensity score-matched study

被引:2
作者
Zhang, Junling [1 ]
Li, Kexuan [2 ]
Zhang, Zongnai [3 ]
Zhang, Guochao [4 ]
Zhang, Shupeng [5 ]
Zhao, Yinming [6 ]
Gao, Zhaoya [7 ]
Ma, Haiyun [8 ]
Xie, Yong [9 ]
Han, Jinsheng [10 ]
Zhang, Li [11 ]
Zhang, Baoliang [12 ]
Liu, Yang [13 ]
Wu, Tao [1 ]
Wu, Yingchao [1 ]
Xiao, Yi [2 ]
Wang, Xin [1 ]
机构
[1] Peking Univ First Hosp, Dept Gastrointestinal Surg, 8 Xishiku St, Beijing 100034, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Gen Surg, Div Colorectal Surg, 1 Shuaifuyuan Wangfujing St, Beijing 100730, Peoples R China
[3] Civil Aviat Gen Hosp, Dept Gen Surg, 1A Gaojing,Chaoyangmenwai Ave, Beijing 100123, Peoples R China
[4] China Japan Friendship Hosp, Dept Gen Surg, 2 East Yinghuayuan St, Beijing 100029, Peoples R China
[5] Tianjin Fifth Cent Hosp, Dept Gen Surg, 41 Zhejiang Rd, Tianjin 300450, Peoples R China
[6] Beijing Jingmei Grp Gen Hosp, Dept Gen Surg, 18 Heishan St, Beijing 102399, Peoples R China
[7] Peking Univ, Dept Gen Surg, Shougang Hosp, 9 Jinyuanzhuang Rd, Beijing 100144, Peoples R China
[8] Beijing Miyun Dist Hosp, Dept Gen Surg, 36 Mixi Rd, Beijing 101500, Peoples R China
[9] Hebei Gen Hosp, Dept Gen Surg, 348 Heping West Rd, Shijiazhuang 050051, Hebei Province, Peoples R China
[10] Cangzhou Integrated Tradit Chinese & Western Med H, Dept Gen Surg, 31 Huanghe West Rd, Cangzhou 061011, Hebei Province, Peoples R China
[11] First Hosp Qinhuangdao, Dept Gen Surg, 258 Wenhua Rd, Qinhuangdao 066000, Hebei Province, Peoples R China
[12] Tangshan Workers Hosp, Dept Gen Surg, 27 Wenhua Rd, Tangshan 063003, Hebei Province, Peoples R China
[13] North China Univ Sci & Technol, Affiliated Hosp, Dept Gen Surg, 73 Jianshe South Rd, Tangshan 063000, Hebei Province, Peoples R China
关键词
Perforated gastric cancer (PGC); Radical gastrectomies; Propensity score matching (PSM); Overall survival (OS); Lymphadenectomy; CHEMOTHERAPY; SURGERY; LYMPHADENECTOMY; METAANALYSIS; MANAGEMENT; CARCINOMA; SURVIVAL;
D O I
10.1186/s12957-023-03283-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective There is no scientific consensus about the treatment of perforated gastric cancer (PGC). Therefore, the aim of this study was to investigate which is the better treatment option for PGC between the single-stage and two-stage strategies.Methods All 81 PGC patients from 13 medical institutions were retrospectively enrolled in this study. The PGC patients who underwent R0 gastrectomy were divided into one-stage surgery and two-stage surgery groups. The clinicopathological characteristics of the two groups were compared, and 415 regular gastric cancer patients without perforation were randomly selected as a control. The propensity score matching (PSM) method was used to find matched regular GC patients with similar clinicopathological parameters. The OS (overall survival) and the number harvested lymph nodes from PGC patients and regular GC patients were compared.Results Compared with PGC patients who underwent one-stage surgery, those who underwent two-stage surgery harvested significantly more lymph nodes [31(27, 38) vs 17 (12, 24), P < 0.001], required less blood transfusion [0 (0, 100) vs 200 (0, 800), P = 0.034], had a shorter ICU stay [0 (0, 1.5) vs 3 (0, 3), P = 0.009], and had a significantly better OS (Median OS: 45 months vs 11 months, P = 0.007). Compared with propensity score-matched regular GC patients without perforation, PGC patients who underwent one-stage gastrectomy had a poorer quality of lymphadenectomy [17 (12, 24) vs 29 (21, 37), P < 0.001] and suffered a worse OS (Median OS: 18 months vs 30 months, P = 0.024). Conversely, two-stage gastrectomy can achieve a comparable quality of lymphadenectomy (P = 0.506) and a similar OS (P = 0.096) compared to propensity score-matched regular GC patients.Conclusions For PGC patients in poor condition, two-stage treatment is a better option when D2 radical gastrectomy cannot be achieved in emergency surgery, based on our findings that two-stage gastrectomy could provide PGC patients with a better quality of lymphadenectomy and a better OS.
引用
收藏
页数:12
相关论文
共 31 条
[1]   Ex Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield [J].
Afaneh, Cheguevara ;
Levy, Adam ;
Selby, Luke ;
Ku, Geoffrey ;
Tang, Laura ;
Yoon, Sam S. ;
Coit, Daniel ;
Strong, Vivian E. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (01) :165-171
[2]   Gastric Cancer, Version 2.2022 [J].
Ajani, Jaffer A. ;
D'Amico, Thomas A. ;
Bentrem, David J. ;
Chao, Joseph ;
Cooke, David ;
Corvera, Carlos ;
Das, Prajnan ;
Enzinger, Peter C. ;
Enzler, Thomas ;
Fanta, Paul ;
Farjah, Farhood ;
Gerdes, Hans ;
Gibson, Michael K. ;
Hochwald, Steven ;
Hofstetter, Wayne L. ;
Ilson, David H. ;
Keswani, Rajesh N. ;
Kim, Sunnie ;
Kleinberg, Lawrence R. ;
Klempner, Samuel J. ;
Lacy, Jill ;
Ly, Quan P. ;
Matkowskyj, Kristina A. ;
McNamara, Michael ;
Mulcahy, Mary F. ;
Outlaw, Darryl ;
Park, Haeseong ;
Perry, Kyle A. ;
Pimiento, Jose ;
Poultsides, George A. ;
Reznik, Scott ;
Roses, Robert E. ;
Strong, Vivian E. ;
Su, Stacey ;
Wang, Hanlin L. ;
Wiesner, Georgia ;
Willett, Christopher G. ;
Yakoub, Danny ;
Yoon, Harry ;
McMillian, Nicole ;
Pluchino, Lenora A. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02) :167-192
[3]   Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) [J].
Baba, Eishi ;
Terashima, Masanori ;
Fujishiro, Mitsuhiro .
GASTRIC CANCER, 2023, 26 (01) :1-25
[4]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[5]   Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study [J].
Brisinda, Giuseppe ;
Chiarello, Maria Michela ;
Crocco, Anna ;
Adams, Neill James ;
Fransvea, Pietro ;
Vanella, Serafino .
WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (03) :381-398
[6]   Necessity of Harvesting At Least 25 Lymph Nodes in Patients With Stage N2-N3 Resectable Gastric Cancer A 10-year, Single-institution Cohort Study [J].
Chen, Hai-Ning ;
Chen, Xin-Zu ;
Zhang, Wei-Han ;
Chen, Xiao-Long ;
Yang, Kun ;
Liu, Jian-Ping ;
Zhang, Bo ;
Chen, Zhi-Xin ;
Chen, Jia-Ping ;
Zhou, Zong-Guang ;
Hu, Jian-Kun .
MEDICINE, 2015, 94 (10)
[7]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[8]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[9]  
2-B
[10]   D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial [J].
Degiuli, M. ;
Reddavid, R. ;
Tomatis, M. ;
Ponti, A. ;
Morino, M. ;
Sasako, M. .
EUROPEAN JOURNAL OF CANCER, 2021, 150 :10-22